Shares of Cassava Sciences (SAVA) are surging higher in pre-market trading today after director Richard Barry disclosed buying shares worth $860,223. SAVA stock also jumped Thursday's after-hours trading following the news. Cassava Sciences is a clinical-stage biotechnology company with a focus on detecting and treating neurodegenerative diseases, such as Alzheimer’s. As per a Form 4 filing, Barry purchased 36,159 shares of Cassava at a weighted average price of $23.79 on August 23. Shares were bought in multiple transactions with prices ranging between $23.52 to $23.92. Post the recent purchases, Barry now owns 186,159 shares of SAVA stock indirectly through a trust.
https://www.tipranks.com/news/cassava-sciences-nasdaqsava-surges-after-director-buys-shares?utm_source=advfn.com&utm_medium=referral
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more Cassava Sciences Charts.
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more Cassava Sciences Charts.